MAS CardioImmune XL Cardiac Marker Control; Model: CAI-XL1; intended for use in the clinical laboratory as an assayed control serum for monitoring assay conditions in specific cardiac marker determinations.
Published December 10, 2014 · Recall initiated: October 20, 2014
Summary
FDA records medical device Class II recall Z-0501-2015, published December 10, 2014 and initiated October 20, 2014. Recalling firm: Microgenics Corporation; Status: Terminated; Reported quantity: 2135 vials.; Lot: Model No.: CAI-XL1; Lot Number: CXL16011, Exp. Date: 2016-01-31. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
MAS CardioImmune XL, level 1 (lot CXL16011), is showing vial-to-vial variation for the analytes Creatine Kinase-MB (CK-MB) and B-Type Natriuretic Peptide-32 (BNP-32).
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Microgenics Corporation
- Distributor
- Worldwide Distribution - USA (nationwide) including Puerto Rico and the states of AR, AZ, CA CO, CT, DE, FL GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI and WY., and the countries of Australia, Canada, China, Germany, Guam, Hong Kong and Taiwan.
- Lot
- Model No.: CAI-XL1; Lot Number: CXL16011, Exp. Date: 2016-01-31.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAMAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETMOctober 21, 2026
- FDAAmerigel Saturated Gauze Dressing Wound managementDecember 10, 2014
- FDAThe Dual Switch Valve is used for fluid drainage from the ventricles into the peritoneum, in cases ofDecember 10, 2014
- FDAMAS Omni Immune PRO ControlsJuly 2, 2014
- FDAMAS Omni Immune ControlsJuly 2, 2014
- FDAThermo Scientific MAS Bilirubin for Siemens and Dimension Vista Systems, , Product is manufactured andJuly 3, 2013
Questions about this recall
Was MAS CardioImmune XL Cardiac Marker Control; Model: CAI-XL1; intended for use in the clinical laboratory as an assayed control serum for monitoring assay conditions in specific cardiac marker determinations. recalled?
Yes. FDA published recall Z-0501-2015 on December 10, 2014. Reported hazard: MAS CardioImmune XL, level 1 (lot CXL16011), is showing vial-to-vial variation for the analytes Creatine Kinase-MB (CK-MB) and B-Type Natriuretic Peptide-32 (BNP-32).
What should I do if I have this product?
Voluntary: Firm initiated · Letter